Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 7/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 1.00 |
| ▸ | TP53 | P04637 | 6/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | ATM | Q13315 | 1/20 | 1.00 |
| ▸ | MDM2 | Q00987 | 4/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.62 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | MAOA | P21397 | 1/20 | 0.62 |
| ▸ | CASP7 | P55210 | 1/20 | 0.62 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Furazolidone SCHEMBL64996 | 1.00 | LMNA (1.00) | LMNAALDH1A1TP53SMN1; SMN2MAPT | |
| Furazolidone SCHEMBL11742425 | 1.00 | LMNA (1.00) | LMNAALDH1A1TP53SMN1; SMN2MAPT | |
| Furazolidone SCHEMBL11235500 | 0.93 | LMNA (0.86) | LMNAALDH1A1TP53SMN1; SMN2MAPT | |
| SCHEMBL30514100 | 0.85 | LMNA (0.74) | LMNAALDH1A1TP53SMN1; SMN2MAPT | |
| Nifuratel SCHEMBL28086242 | 0.84 | LMNA (0.70) | LMNAALDH1A1TP53SMN1; SMN2MAPT | |
| Furazolidone SCHEMBL29754412 | 0.82 | LMNA (0.70) | LMNAALDH1A1TP53SMN1; SMN2MAPT | |
| Nifuradene SCHEMBL151225 | 0.82 | LMNA (0.69) | LMNAALDH1A1TP53SMN1; SMN2MAPT | |
| Nifuradene SCHEMBL151226 | 0.82 | LMNA (0.69) | LMNAALDH1A1TP53SMN1; SMN2MAPT | |
| Furazolidone SCHEMBL28086650 | 0.80 | LMNA (0.64) | LMNAALDH1A1TP53SMN1; SMN2MAPT | |
| SCHEMBL14069664 | 0.78 | MAPT (0.64) | LMNAALDH1A1TP53SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 15359 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-20260091119-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF GLIOMA | CELLIS AG (CH) | 2026-04-02 | — | — | US | claimed |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-20260027140-A1 | COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA | ATOPIC MEDICAL INC (US) | 2026-01-29 | — | — | US | claimed |
| US-12465623-B2 | Use of parasites and extracellular vesicles obtained from parasites in cancer treatment | YEDITEPE UNIVERSITESI (TR) | 2025-11-11 | — | — | US | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4637829-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF OVARIAN CANCER | Cellis Sp. z o.o. ([Ltd.] (PL) | 2025-10-29 | — | — | EP | claimed |
| US-4591545-A | Photosensitive image-forming material having a layer of photosensitive polyester modified with chain extender | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1986-05-27 | — | — | US | claimed |
| EP-0146738-A2 | Antimicrobial animal feed additive compositions | AMERICAN CYANAMID COMPANY (US) | 1985-07-03 | — | — | EP | claimed |
| US-4402965-A | FURAZOLIDONE | Simoons, John R. A. (US) | 1983-09-06 | — | — | US | claimed |
| US-4235236-A | Device for dispensing drug by combined diffusional and osmotic operations | ALZA CORPORATION (US) | 1980-11-25 | — | — | US | claimed |
| US-4112230-A | Δ2,3 -1,4 Morpholine-2-carboxylic acid derivatives as antibacterial agents | BRISTOL-MYERS COMPANY (US) | 1978-09-05 | — | — | US | claimed |
| US-4102998-A | INTRAUTERINE DEVICE WHICH RELEASES MEDICATION | GUTNICK MORTON | 1978-07-25 | — | — | US | claimed |
| US-4053593-A | PREVENTING AND CURING DISEASES IN FISH | FRUMOFF LEW | 1977-10-11 | — | — | US | claimed |
| US-4049817-A | MICROBIOCIDE 6-CHLORO-BENZISOTHIAZOLINONE AND A 2-NITRO-FURYL OR 2-NITRO-THIENYL COMPOUND | SANDOZ LTD. (CH) | 1977-09-20 | — | — | US | claimed |
| US-4024327-A | Baking finishes which do not pollute the environment | BASF AKTIENGESELLSCHAFT (DT) | 1977-05-17 | — | — | US | claimed |
| US-3980434-A | THIN LAYER CHROMATOGRAPHY, FLUORESCENCE | MORTON-NORWICH PRODUCTS, INC. (US) | 1976-09-14 | — | — | US | claimed |